Skip to main content

Current Every Day Smoker clinical trials at UC Health
1 in progress, 0 open to new patients

  • Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers

    Sorry, in progress, not accepting new patients

    This randomized phase II trial studies the effects of aspirin and zileuton on genes related to tobacco use in current smokers. Aspirin and zileuton may interfere with genes related to tobacco use and may be useful in preventing lung cancer in current smokers.

    at UC Davis

Last updated: